Keyword: migraine

News

Eli Lilly Takes US Biopharma CoLucid

23.01.2017 - Eli Lilly is paying around $960 million to acquire biopharma CoLucid, boosting the US drugmaker’s portfolio for migraine pain management and adding a late-stage candidate with a...

News

Novartis and Amgen Partner on Alzheimer’s and Migraine

03.09.2015 - Swiss drugmaker Novartis has announced it will cooperate with US biopharmaceutical group Amgen to develop and sell neuroscience treatments for conditions such as Alzheimer's...